De Rucci Valuation

001323 Stock   40.02  1.48  3.57%   
At this time, the firm appears to be overvalued. De Rucci Healthy owns a latest Real Value of USD31.87 per share. The recent price of the firm is USD40.02. Our model computes the value of De Rucci Healthy from analyzing the firm fundamentals such as Return On Asset of 0.0753, price to book of 3.65 X, and Current Valuation of 13.41 B as well as examining its technical indicators and probability of bankruptcy.
Price Book
3.6499
Enterprise Value
13.4 B
Enterprise Value Ebitda
13.6601
Price Sales
3.0378
Trailing PE
20.4434
Overvalued
Today
40.02
Please note that De Rucci's price fluctuation is very steady at this time. Calculation of the real value of De Rucci Healthy is based on 3 months time horizon. Increasing De Rucci's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since De Rucci is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 001323 Stock. However, De Rucci's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  40.02 Real  31.87 Hype  41.5
The real value of 001323 Stock, also known as its intrinsic value, is the underlying worth of De Rucci Healthy Company, which is reflected in its stock price. It is based on De Rucci's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of De Rucci's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
31.87
Real Value
45.65
Upside
Estimating the potential upside or downside of De Rucci Healthy helps investors to forecast how 001323 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of De Rucci more accurately as focusing exclusively on De Rucci's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.510.510.52
Details
Hype
Prediction
LowEstimatedHigh
38.8041.5044.20
Details

De Rucci Cash

1.69 Billion

De Rucci Total Value Analysis

De Rucci Healthy is presently forecasted to have takeover price of 13.41 B with market capitalization of 16.6 B, debt of 441.91 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the De Rucci fundamentals before making investing decisions based on enterprise value of the company

De Rucci Investor Information

About 85.0% of the company shares are owned by insiders or employees . The book value of De Rucci was presently reported as 11.05. The company last dividend was issued on the 27th of September 2024. Based on the key indicators obtained from De Rucci's historical financial statements, De Rucci Healthy is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities1.2 B1.9 B
Way Down
Slightly volatile
Operating Income794.3 M893 M
Fairly Down
Slightly volatile

De Rucci Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. De Rucci has an asset utilization ratio of 78.0 percent. This suggests that the Company is making USD0.78 for each dollar of assets. An increasing asset utilization means that De Rucci Healthy is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

De Rucci Ownership Allocation

De Rucci Healthy secures a total of 400.01 Million outstanding shares. De Rucci Healthy owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 85.12 % of De Rucci Healthy outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.

De Rucci Profitability Analysis

The company reported the revenue of 5.58 B. Net Income was 802.27 M with profit before overhead, payroll, taxes, and interest of 2.7 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates De Rucci's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in De Rucci and how it compares across the competition.

About De Rucci Valuation

The stock valuation mechanism determines De Rucci's current worth on a weekly basis. Our valuation model uses a comparative analysis of De Rucci. We calculate exposure to De Rucci's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of De Rucci's related companies.
Last ReportedProjected for Next Year
Gross Profit2.8 B2.8 B

De Rucci Quarterly Retained Earnings

1.29 Billion

Complementary Tools for 001323 Stock analysis

When running De Rucci's price analysis, check to measure De Rucci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy De Rucci is operating at the current time. Most of De Rucci's value examination focuses on studying past and present price action to predict the probability of De Rucci's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move De Rucci's price. Additionally, you may evaluate how the addition of De Rucci to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.